NEUROCHEMICAL EVIDENCE OF CARDIAC SYMPATHETIC ACTIVATION AND INCREASED CENTRAL-NERVOUS-SYSTEM NOREPINEPHRINE TURNOVER IN SEVERE CONGESTIVE-HEART-FAILURE

被引:233
作者
KAYE, DM [1 ]
LAMBERT, GW [1 ]
LEFKOVITS, J [1 ]
MORRIS, M [1 ]
JENNINGS, G [1 ]
ESLER, MD [1 ]
机构
[1] DEAKIN UNIV, SCH BIOL & CHEM SCI, GEELONG, VIC, AUSTRALIA
基金
英国医学研究理事会;
关键词
D O I
10.1016/0735-1097(94)90738-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The aim of this study was to characterize cardiac sympathetic nervous function in patients with severe heart failure and to investigate the influence of the cause of heart failure, hemodynamic variables and central nervous system catecholamine release on cardiac sympathetic tone. Background. Although heart failure is generally accompanied by sympathoexcitation, the integrity of cardiac sympathetic nerve function in heart failure remains controversial, particularly in relation to nerve firing activity and to the capacity of sympathetic nerves to recapture norepinephrine. Additionally, the location of the afferent and central neural pathways implicated in heart failure-induced sympathoexcitation remains unclear. Methods. Radiotracer techniques were applied in 41 patients with severe heart failure and 15 healthy control subjects to study the biochemical aspects of whole body and cardiac sympathetic activity. Hemodynamic indexes of cardiac performance were measured in the heart failure group, and their association with sympathetic activity was studied. Jugular venous catechol spillover was measured to study the central noradrenergic control of sympathetic outflow. Results. Sympathoexcitation was evident in the heart failure group, reflected by a 62% increase (p < 0.001) in total body and a 277% increase (p < 0.001) in cardiac norepinephrine spillover rates. These changes were accompanied by significant increases in the cardiac spillover of the norepinephrine precursor dihydroxyphenylalanine, the sympathetic cotransmitter neuropeptide Y and the extraneuronal metabolite 3-methoxy-4-hydroxyphenylglycol. The level of cardiac sympathetic activity was significantly correlated (r = 0.59, p < 0.001) with the mean pulmonary artery pressure. An increase in the spillover of dihydroxyphenylalanine and 3-methoxy-4-hydroxyphenylglycol from the brain was present, suggesting activation of central noradrenergic neurons. Conclusions. Cardiac sympathetic activation is present in severe heart failure, bearing a close relation with pulmonary artery pressures, independent of heart failure etiology. Activation of noradrenergic neurons in the brain is also present and may be the underlying central nervous mechanism of the sympathoexcitation observed in heart failure.
引用
收藏
页码:570 / 578
页数:9
相关论文
共 65 条
[1]   CELL GROUPS IN THE LOWER BRAIN-STEM OF THE RABBIT PROJECTING TO THE SPINAL-CORD, WITH SPECIAL REFERENCE TO CATECHOLAMINE-CONTAINING NEURONS [J].
BLESSING, WW ;
GOODCHILD, AK ;
DAMPNEY, RAL ;
CHALMERS, JP .
BRAIN RESEARCH, 1981, 221 (01) :35-55
[2]   CARDIAC AND PULMONARY NOREPINEPHRINE RELEASE AND REMOVAL IN THE DOG [J].
BLOMBERY, PA ;
HEINZOW, BGJ .
CIRCULATION RESEARCH, 1983, 53 (05) :688-694
[3]   PATHOPHYSIOLOGIC AND PHARMACOLOGICAL RATIONALES FOR CLINICAL MANAGEMENT OF CHRONIC HEART-FAILURE WITH BETA-BLOCKING-AGENTS [J].
BRISTOW, MR .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (09) :C12-C22
[4]   DIFFERENCES IN BETA-ADRENERGIC NEUROEFFECTOR MECHANISMS IN ISCHEMIC VERSUS IDIOPATHIC DILATED CARDIOMYOPATHY [J].
BRISTOW, MR ;
ANDERSON, FL ;
PORT, JD ;
SKERL, L ;
HERSHBERGER, RE ;
LARRABEE, P ;
OCONNELL, JB ;
RENLUND, DG ;
VOLKMAN, K ;
MURRAY, J ;
FELDMAN, AM .
CIRCULATION, 1991, 84 (03) :1024-1039
[5]   BRAIN-STEM AND BULBOSPINAL NEUROTRANSMITTER SYSTEMS IN THE CONTROL OF BLOOD-PRESSURE [J].
CHALMERS, J ;
PILOWSKY, P .
JOURNAL OF HYPERTENSION, 1991, 9 (08) :675-694
[6]   PARTICIPATION OF CENTRAL NORADRENERGIC NEURONS IN ARTERIAL BARORECEPTOR REFLEXES IN RABBIT - STUDY WITH INTRACISTERNALLY ADMINISTERED 6-HYDROXYDOPAMINE [J].
CHALMERS, JP ;
REID, JL .
CIRCULATION RESEARCH, 1972, 31 (05) :789-+
[7]   PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE [J].
COHN, JN ;
LEVINE, TB ;
OLIVARI, MT ;
GARBERG, V ;
LURA, D ;
FRANCIS, GS ;
SIMON, AB ;
RECTOR, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) :819-823
[8]   INTRACORONARY INFUSION OF DOBUTAMINE TO PATIENTS WITH AND WITHOUT SEVERE CONGESTIVE HEART-FAILURE - DOSE-RESPONSE RELATIONSHIPS, CORRELATION WITH CIRCULATING CATECHOLAMINES, AND EFFECT OF PHOSPHODIESTERASE INHIBITION [J].
COLUCCI, WS ;
DENNISS, AR ;
LEATHERMAN, GF ;
QUIGG, RJ ;
LUDMER, PL ;
MARSH, JD ;
GAUTHIER, DF .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (04) :1103-1110
[9]  
CRISP AJ, 1988, J PHYSIOL-LONDON, V407, P1
[10]   ABNORMALITIES IN SYSTEMIC NOREPINEPHRINE KINETICS IN HUMAN CONGESTIVE HEART-FAILURE [J].
DAVIS, D ;
BAILY, R ;
ZELIS, R .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (06) :E760-E766